Pharmaceutical companies face a stark reality: only 1 in 5,000 drug candidates reaches market approval, R&D return on investment has dropped to just 1.2%, and bringing a new treatment to market costs between $2.6 and $6.7 billion. Traditional approaches to process design and technology transfer rely on extensive physical experiments, fragmented data and siloed teams, making fast and efficient scale-up nearly impossible.
Digital transformation changes that equation. A connected digital thread spanning formulation, process design and technology transfer acts as a single source of truth, breaking down silos and enabling teams to collaborate across every stage of development.
Siemens Simcenter offers a comprehensive, AI-powered simulation portfolio designed for the pharmaceutical industry. The ebook walks through six capability areas that help you reduce physical experimentation, accelerate scale-up and improve drug manufacturability:
This ebook covers each Siemens Simcenter capability in detail, with industry data, expert quotes from pharmaceutical practitioners and a clear picture of how simulation and Digital Twin technology fit into the pharmaceutical development lifecycle.
Download the ebook to see how Simcenter can help you accelerate drug development, reduce waste and scale up from lab to production with greater speed and confidence.